Answers are grounded in this paper and cite their sources.
Alpha-1 antitrypsin (AAT) deficiency (AATD) is the second most common genetic disease to cause clinically significant lung disease, surpassed only by cystic fibrosis.1 AAT is a serine protease inhibitor primarily produced in hepatocytes, with a normal plasma level of 20â53 µM or 90â200 mg/dL and a half-life of 3â5 days.2 AAT is transported via the systemic circulation […]
No takes yet. Share an insight, caveat, or question.
Goel et al. (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: